Futura Medical PLC Remuneration of NED and Total Voting Rights (6268A)
22 Gennaio 2020 - 03:33PM
UK Regulatory
TIDMFUM
RNS Number : 6268A
Futura Medical PLC
22 January 2020
Remuneration of Non-Executive Directors and Total Voting
Rights
22 January 2020
Futura Medical plc (AIM: FUM) (the "Company"), a pharmaceutical
company developing a portfolio of innovative products for sexual
health and pain relief, announces the issue of 341,659 new ordinary
shares of 0.2 pence each ("Ordinary Shares") in respect of the 2019
remuneration of its Non-Executive Directors.
In accordance with the terms of their service agreements, the
Non-Executive Directors receive approximately 30 per cent of their
remuneration in the form of Ordinary Shares. For 2019, these were
issued at 6.01 pence per share, being the average closing
mid-market price of the last 10 trading days of 2018 (as announced
via RNS on 11 January 2019).
The 341,659 new Ordinary Shares shall rank pari passu with the
existing issued Ordinary Shares of the Company and have been issued
as follows:
Director Number of Ordinary Shares Total number of ordinary shares Percentage of the Company's
issued for 2019 remuneration held resulting issued share capital
John Clarke 256,562 512,788 0.21%
Jonathan Freeman 85,097 175,718 0.07%
Application has been made to the London Stock Exchange and it is
anticipated that trading of the new Ordinary Shares will commence
on AIM at 8:00am on 28 January 2020.
Immediately following the above issue, the Company will have
245,626,926 ordinary shares in issue, each carrying one voting
right. Since the Company currently holds no shares in treasury, the
total number of voting rights in the Company is therefore
245,626,926 and this figure may be used by Shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure Guidance and Transparency Rules.
The shares element of the Non-Executive Directors' remuneration
for 2020 will be awarded at 12.24 pence per Ordinary Share, being
the average closing mid-market price of the last 10 trading days of
2019. The Non-Executive Directors will receive these shares in
January 2021.
Further details are contained within the notifications below,
made in accordance with Article 19 of the EU Market Abuse
Regulation 596/2014. Full details of the Non-Executive Directors'
remuneration will be included in the Company's Annual Report &
Accounts.
ENDS
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
www.Futuramedical.com
Nominated Adviser and Sole Broker:
Liberum
Bidhi Bhoma/ Euan Brown/ Kane Collings
Tel: +44 (0) 20 3100 2000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Eva Haas/ Hollie Vile
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
Notes to editors
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) drug delivery technology.
These products are optimised for clinical efficacy, safety,
administration and patient convenience and are developed for the
prescription and consumer healthcare markets as appropriate.
Current therapeutic areas are sexual health, including erectile
dysfunction, and pain relief. Development and commercialisation
strategies are designed to maximise product differentiation and
value creation whilst minimising risk.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name John Clarke
------------------------------ -----------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
6.01 pence 256,562
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 22 January 2020
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Jonathan Freeman
------------------------------ -----------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
6.01 pence 85,097
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 22 January 2020
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRUUOSRRAUAUAR
(END) Dow Jones Newswires
January 22, 2020 09:33 ET (14:33 GMT)
Grafico Azioni Futura Medical (LSE:FUM)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Futura Medical (LSE:FUM)
Storico
Da Mar 2023 a Mar 2024